Stephen Hill, Director at Gyre Therapeutics, holds 12.75K shares in Lipocine (Ticker: LPCN), holds 18.00K shares in Cellectar Biosciences (Ticker: CLRB), holds 1.19K shares in Gyre Therapeutics (Ticker: GYRE).
What is the percentage of profitable transactions made by Stephen Hill?
The percentage of profitable transactions made by Stephen Hill is 67%.
What is the average return per transaction made by Stephen Hill?
The average return per transaction made by Stephen Hill is 27.40%.
What stocks does Stephen Hill hold?
Stephen Hill holds: GYRE, LPCN, ARQL, CLRB stocks.
What was Stephen Hill’s latest transaction?
Stephen Hill latest transaction was an Uninformative Buy of $10.35K.
What was Stephen Hill's most profitable transaction?
Stephen Hill’s most profitable transaction was an Informative Buy of LPCN stock on November 13, 2014. The return on the trade was 166.00%.
What is Stephen Hill's role in Gyre Therapeutics?
Stephen Hill's role in Gyre Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.